95 related articles for article (PubMed ID: 33250425)
1. Rapid rise in the cost of targeted cancer therapies for Medicare patients with solid tumors from 2006 to 2015.
Wilson LE; Greiner MA; Altomare I; Rotter J; Dinan MA
J Geriatr Oncol; 2021 Apr; 12(3):375-380. PubMed ID: 33250425
[TBL] [Abstract][Full Text] [Related]
2. Association between the Medicare hospice benefit and health care utilization and costs for patients with poor-prognosis cancer.
Obermeyer Z; Makar M; Abujaber S; Dominici F; Block S; Cutler DM
JAMA; 2014 Nov; 312(18):1888-96. PubMed ID: 25387186
[TBL] [Abstract][Full Text] [Related]
3. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
[TBL] [Abstract][Full Text] [Related]
4. The Cost of Metastatic Prostate Cancer in the United States.
Olsen TA; Filson CP; Richards TB; Ekwueme DU; Howard DH
Urol Pract; 2023 Jan; 10(1):41-47. PubMed ID: 37103444
[TBL] [Abstract][Full Text] [Related]
5. The cost of cancer-related physician services to Medicare.
Maroongroge S; Kim SP; Mougalian S; Johung K; Decker RH; Soulos PR; Long JB; Gross CP; Yu JB
Yale J Biol Med; 2015 Jun; 88(2):107-14. PubMed ID: 26029009
[TBL] [Abstract][Full Text] [Related]
6. Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015.
Yeung H; Baranowski ML; Swerlick RA; Chen SC; Hemingway J; Hughes DR; Duszak R
JAMA Dermatol; 2018 Nov; 154(11):1281-1285. PubMed ID: 30326488
[TBL] [Abstract][Full Text] [Related]
7. Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure.
Fitch K; Pelizzari PM; Pyenson B
Am Health Drug Benefits; 2016 Apr; 9(2):96-104. PubMed ID: 27182428
[TBL] [Abstract][Full Text] [Related]
8. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
Chen CT; Li L; Brooks G; Hassett M; Schrag D
Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
[TBL] [Abstract][Full Text] [Related]
9. Area-level variations in cancer care and outcomes.
Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
[TBL] [Abstract][Full Text] [Related]
10. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
Penberthy L; Retchin SM; McDonald MK; McClish DK; Desch CE; Riley GF; Smith TJ; Hillner BE; Newschaffer CJ
Health Care Manag Sci; 1999 Jul; 2(3):149-60. PubMed ID: 10934539
[TBL] [Abstract][Full Text] [Related]
12. Trends of Expenditures and Utilization of Facet Joint Interventions in Fee-For-Service (FFS) Medicare Population from 2009-2018.
Manchikanti L; Pampati V; Soin A; Vanaparthy R; Sanapati MR; Kaye AD; Hirsch JA
Pain Physician; 2020 May; 23(3S):S129-S147. PubMed ID: 32503360
[TBL] [Abstract][Full Text] [Related]
13. Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013.
Krumholz HM; Nuti SV; Downing NS; Normand SL; Wang Y
JAMA; 2015 Jul; 314(4):355-65. PubMed ID: 26219053
[TBL] [Abstract][Full Text] [Related]
14. Declining Utilization and Inflation-Adjusted Expenditures for Epidural Procedures in Chronic Spinal Pain in the Medicare Population.
Manchikanti L; Pampati V; Soin A; Sanapati MR; Kaye AD; Hirsch JA
Pain Physician; 2021 Jan; 24(1):1-15. PubMed ID: 33400424
[TBL] [Abstract][Full Text] [Related]
15. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
[TBL] [Abstract][Full Text] [Related]
17. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
[TBL] [Abstract][Full Text] [Related]
18. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Long-Term Prescription Opioid Use Among Older Adults in the United States: A Study of Medicare Administrative Claims Data.
Ramachandran S; Salkar M; Bentley JP; Eriator I; Yang Y
Pain Physician; 2021 Jan; 24(1):31-40. PubMed ID: 33400426
[TBL] [Abstract][Full Text] [Related]
20. Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers.
Feng X; Higa GM; Safarudin F; Sambamoorthi U; Tan X
J Geriatr Oncol; 2019 Sep; 10(5):698-704. PubMed ID: 30772191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
